Two small-cap healthcare companies, Cardiff Oncology and CytomX Therapeutics, are listed on NASDAQ and receive analyst recommendations from MarketBeat.
1 report, 1 independent
Updated Sep 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Two small-cap healthcare companies, Cardiff Oncology and CytomX Therapeutics, are listed on NASDAQ and receive analyst recommendations from MarketBeat.
Who's involved
What this event is mainly aboutKeep exploring
Part of
MarketBeat provided analyst recommendations for companies listed on the Nasdaq exchange.Also in this story
- MarketBeat reported analyst recommendations for AMCI Acquisition Corp., which is listed on the Nasdaq electronic stock exchange.
- Versant was listed on the electronic stock exchange and received analyst recommendations from MarketBeat.
The entities involved
-
MarketBeat
American personal finance blog
-
Nasdaq
American fully electronic stock exchange
Related events
- Xenetic Biosciences and XTL Biopharmaceuticals are competing in the small-cap biopharmaceutical space, listed on the Nasdaq stock exchange.
- ProKidney and Cartesian Therapeutics were listed on the Nasdaq stock exchange and received ratings from MarketBeat.
- HCW Biologics announced it is listed on the Nasdaq stock exchange.
- Argenex SE and Capricor Therapeutics were listed on the Nasdaq stock exchange and are competing in the biotech sector.
- MarketBeat provides stock rating data for Vivos Therapeutics, which is listed on Nasdaq.